JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
RGEN Financials - Repligen Income & Cash Flow | Ledgeburg
RGEN - Repligen Corp.
USD | NASDAQ | Healthcare
Summary
Summary RGEN Stock
Financials
Financials RGEN Stock
Loading...
Loading...
Income Statement
Income Statement RGEN Stock
Balance Sheet
Balance Sheet RGEN Stock
Cash Flow Statement
Cash Flow Statement RGEN Stock
Loading...
Loading...
Home
Stocks
Repligen Corp. (RGEN)
Financials
Financials of RGEN
Loading...
Loading...
Loading...
Loading...
Revenue
$738.256M
Operating Income
$55.167M
Net Income
$48.894M
Share Count (Basic)
56.234K
Operating Cash Flow
$117.417M
Free Cash Flow
$93.898M
Cash And Short-Term Equivalents
$767.628M
Total Debt
$542.213M
Annual
Quarterly
Revenue $USD
0
200M
400M
600M
800M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
50M
100M
150M
200M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
0
50M
100M
150M
200M
Annual
Quarterly
Margins
Gross
Operating
Net
0%
20%
40%
60%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
0
5M
10M
15M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
0%
20%
40%
60%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26